Efficacy and safety of CT-P59 plus standard of care: a phase 2/3 randomized, double-blind, placebo-controlled trial in outpatients with mild-to-moderate SARS-CoV-2 infection
Research Square (2021) - Comments
doi: 10.21203/rs.3.rs-296518/v1 

Joong Sik Eom, Michael Ison, Anca Streinu-Cercel, Oana Săndulescu, Liliana-Lucia Preotescu, Yeon-Sook Kim, Jin Yong Kim, Shin Hyea Cheon, Young Rock Jang, Sang Joon Lee, Sung Hyun Kim, Ilsung Chang, Jee Hye Suh, Seul Gi Lee, Mi Rim Kim, Da Rae Chung, Han Na Kim, Adrian Streinu-Cercel